查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1530933

基因分型检测市场 - 全球产业分析、规模、份额、成长、趋势和预测，2024-2034 年

Genotyping Assays Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 198 Pages | 商品交期: 2-10个工作天内

价格

基因分型检测市场 - 报告范围

TMR 关于全球基因分型检测市场的报告研究了过去以及当前的成长趋势和机会，以获得 2024 年至 2034 年预测期内市场指标的宝贵见解。 -2034年期间，考虑2024年为基准年，2034年为预测年。该报告也提供了2024年至2034年全球基因分型检测市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解基因分型检测市场。

市场概况
2023年市场价值 305 亿美元
2034 年市场价值 2853 亿美元
复合年增长率 22.5%

该报告深入探讨了全球基因分型检测市场的竞争格局。全球基因分型检测市场的主要参与者已被确定，并且每位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球基因分型检测市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：依产品与服务分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按产品和服务，2020-2034
    • 试剂和试剂盒
    • 基因分型服务
    • 仪器仪表
      • 序列和放大器
      • 分析仪
    • 生物资讯学
      • 软体
      • 服务
  • 市场吸引力：按产品和服务分类

第 7 章：全球市场分析与预测：依技术分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依技术分类，2020-2034
    • 聚合酶炼式反应
      • 实时定量PCR
      • 数位PCR
    • 微阵列
    • 定序
      • NGS
      • 焦磷酸定序
      • 桑格定序
    • 毛细管电泳
      • 扩增片段长度多态性
      • 限制性片段长度多态性
      • 单股构像多态性
    • 飞行时间飞行时间
    • 其他（等位基因特异性寡核苷酸（ASO）探针、萤光原位杂交（FISH）等）
  • 市场吸引力：依技术分类

第 8 章：全球市场分析与预测：按应用

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依应用分类，2020-2034
    • 药物基因组学
    • 诊断及个人化医疗
    • 农业生物技术
    • 动物遗传学
    • 其他（产前检测、人体法医学、微生物基因组研究、水产养殖育种研究等）
  • 市场吸引力：按应用分类

第 9 章：全球市场分析与预测：按最终用户

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2020-2034
    • 製药及生物製药公司
    • 诊断与研究实验室
    • 学术机构
    • 其他（动物和水产遗传学公司等）
  • 市场吸引力：按最终用户划分

第 10 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2020-2034
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力：按地区

第 11 章：北美市场分析与预测

第 12 章：欧洲市场分析与预测

第 13 章：亚太市场分析与预测

第 14 章：拉丁美洲市场分析与预测

第 15 章：中东和非洲市场分析与预测

第16章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司分类（2023）
  • 公司简介
    • Illumina, Inc.
    • Thermo Fisher Scientific
    • QIAGEN NV
    • Agilent
    • Danaher Corporation
    • Roche
    • GE HealthCare
    • Standard BioTools Inc.
    • PerkinElmer
    • Eurofins Scientific SE
    • Bio-Rad Laboratories
    • Pacific Biosciences of California, Inc.
    • GENEWIZ, Inc.
    • Integrated DNA Technologies, Inc.
Product Code: TMRGL54549

Genotyping Assays Market - Scope of Report

TMR's report on the global genotyping assays market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global genotyping assays market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global genotyping assays market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the genotyping assays market.

Market Snapshot
Market Value in 2023US$ 30.5 Bn
Market Value in 2034US$ 285.3 Bn
CAGR22.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global genotyping assays market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global genotyping assays market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global genotyping assays market.

The report delves into the competitive landscape of the global genotyping assays market. Key players operating in the global genotyping assays market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global genotyping assays market profiled in this report.

Key Questions Answered in Global genotyping assays Market Report:

  • What is the sales/revenue generated by genotyping assays across all regions during the forecast period?
  • What are the opportunities in the global genotyping assays market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Genotyping Assays Market - Research Objectives and Research Approach

The comprehensive report on the global genotyping assays market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global genotyping assays market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global genotyping assays market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Genotyping Assays Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Genotyping Assays Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Genotyping Assays Market Analysis and Forecast, by Product & Service

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product & Service, 2020-2034
    • 6.3.1. Reagents & Kits
    • 6.3.2. Genotyping Services
    • 6.3.3. Instruments
      • 6.3.3.1. Sequences & Amplifiers
      • 6.3.3.2. Analyzers
    • 6.3.4. Bioinformatics
      • 6.3.4.1. Software
      • 6.3.4.2. Services
  • 6.4. Market Attractiveness, by Product & Service

7. Global Genotyping Assays Market Analysis and Forecast, by Technology

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technology, 2020-2034
    • 7.3.1. PCR
      • 7.3.1.1. Real-time PCR
      • 7.3.1.2. Digital PCR
    • 7.3.2. Microarrays
    • 7.3.3. Sequencing
      • 7.3.3.1. NGS
      • 7.3.3.2. Pyrosequencing
      • 7.3.3.3. Sanger Sequencing
    • 7.3.4. Capillary Electrophoresis
      • 7.3.4.1. Amplified Fragment Length Polymorphism
      • 7.3.4.2. Restricted Fragment Length Polymorphism
      • 7.3.4.3. Single-Stranded Conformation Polymorphism
    • 7.3.5. MALDI-TOF
    • 7.3.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
  • 7.4. Market Attractiveness, by Technology

8. Global Genotyping Assays Market Analysis and Forecast, by Application

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2020-2034
    • 8.3.1. Pharmacogenomics
    • 8.3.2. Diagnostic & Personalized Medicine
    • 8.3.3. Agricultural Biotechnology
    • 8.3.4. Animal Genetics
    • 8.3.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
  • 8.4. Market Attractiveness, by Application

9. Global Genotyping Assays Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2020-2034
    • 9.3.1. Pharmaceutical & Biopharmaceutical Companies
    • 9.3.2. Diagnostic & Research Laboratories
    • 9.3.3. Academic Institutes
    • 9.3.4. Others (Animal and Aquagenetics Companies, etc.)
  • 9.4. Market Attractiveness, by End-user

10. Global Genotyping Assays Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020-2034
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America Genotyping Assays Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product & Service, 2020-2034
    • 11.2.1. Reagents & Kits
    • 11.2.2. Genotyping Services
    • 11.2.3. Instruments
      • 11.2.3.1. Sequences & Amplifiers
      • 11.2.3.2. Analyzers
    • 11.2.4. Bioinformatics
      • 11.2.4.1. Software
      • 11.2.4.2. Services
  • 11.3. Market Attractiveness, by Product & Service
  • 11.4. Market Value Forecast, by Technology, 2020-2034
    • 11.4.1. PCR
      • 11.4.1.1. Real-time PCR
      • 11.4.1.2. Digital PCR
    • 11.4.2. Microarrays
    • 11.4.3. Sequencing
      • 11.4.3.1. NGS
      • 11.4.3.2. Pyrosequencing
      • 11.4.3.3. Sanger Sequencing
    • 11.4.4. Capillary Electrophoresis
      • 11.4.4.1. Amplified Fragment Length Polymorphism
      • 11.4.4.2. Restricted Fragment Length Polymorphism
      • 11.4.4.3. Single-Stranded Conformation Polymorphism
    • 11.4.5. MALDI-TOF
    • 11.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
  • 11.5. Market Attractiveness, by Technology
  • 11.6. Market Value Forecast, by Application, 2020-2034
    • 11.6.1. Pharmacogenomics
    • 11.6.2. Diagnostic & Personalized Medicine
    • 11.6.3. Agricultural Biotechnology
    • 11.6.4. Animal Genetics
    • 11.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
  • 11.7. Market Attractiveness, by Application
  • 11.8. Market Value Forecast, by End-user, 2020-2034
    • 11.8.1. Pharmaceutical & Biopharmaceutical Companies
    • 11.8.2. Diagnostic & Research Laboratories
    • 11.8.3. Academic Institutes
    • 11.8.4. Others (Animal and Aquagenetics Companies, etc.)
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Product & Service
    • 11.11.2. By Technology
    • 11.11.3. By Application
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe Genotyping Assays Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product & Service, 2020-2034
    • 12.2.1. Reagents & Kits
    • 12.2.2. Genotyping Services
    • 12.2.3. Instruments
      • 12.2.3.1. Sequences & Amplifiers
      • 12.2.3.2. Analyzers
    • 12.2.4. Bioinformatics
      • 12.2.4.1. Software
      • 12.2.4.2. Services
  • 12.3. Market Attractiveness, by Product & Service
  • 12.4. Market Value Forecast, by Technology, 2020-2034
    • 12.4.1. PCR
      • 12.4.1.1. Real-time PCR
      • 12.4.1.2. Digital PCR
    • 12.4.2. Microarrays
    • 12.4.3. Sequencing
      • 12.4.3.1. NGS
      • 12.4.3.2. Pyrosequencing
      • 12.4.3.3. Sanger Sequencing
    • 12.4.4. Capillary Electrophoresis
      • 12.4.4.1. Amplified Fragment Length Polymorphism
      • 12.4.4.2. Restricted Fragment Length Polymorphism
      • 12.4.4.3. Single-Stranded Conformation Polymorphism
    • 12.4.5. MALDI-TOF
    • 12.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
  • 12.5. Market Attractiveness, by Technology
  • 12.6. Market Value Forecast, by Application, 2020-2034
    • 12.6.1. Pharmacogenomics
    • 12.6.2. Diagnostic & Personalized Medicine
    • 12.6.3. Agricultural Biotechnology
    • 12.6.4. Animal Genetics
    • 12.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
  • 12.7. Market Attractiveness, by Application
  • 12.8. Market Value Forecast, by End-user, 2020-2034
    • 12.8.1. Pharmaceutical & Biopharmaceutical Companies
    • 12.8.2. Diagnostic & Research Laboratories
    • 12.8.3. Academic Institutes
    • 12.8.4. Others (Animal and Aquagenetics Companies, etc.)
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Product & Service
    • 12.11.2. By Technology
    • 12.11.3. By Application
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific Genotyping Assays Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product & Service, 2020-2034
    • 13.2.1. Reagents & Kits
    • 13.2.2. Genotyping Services
    • 13.2.3. Instruments
      • 13.2.3.1. Sequences & Amplifiers
      • 13.2.3.2. Analyzers
    • 13.2.4. Bioinformatics
      • 13.2.4.1. Software
      • 13.2.4.2. Services
  • 13.3. Market Attractiveness, by Product & Service
  • 13.4. Market Value Forecast, by Technology, 2020-2034
    • 13.4.1. PCR
      • 13.4.1.1. Real-time PCR
      • 13.4.1.2. Digital PCR
    • 13.4.2. Microarrays
    • 13.4.3. Sequencing
      • 13.4.3.1. NGS
      • 13.4.3.2. Pyrosequencing
      • 13.4.3.3. Sanger Sequencing
    • 13.4.4. Capillary Electrophoresis
      • 13.4.4.1. Amplified Fragment Length Polymorphism
      • 13.4.4.2. Restricted Fragment Length Polymorphism
      • 13.4.4.3. Single-Stranded Conformation Polymorphism
    • 13.4.5. MALDI-TOF
    • 13.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
  • 13.5. Market Attractiveness, by Technology
  • 13.6. Market Value Forecast, by Application, 2020-2034
    • 13.6.1. Pharmacogenomics
    • 13.6.2. Diagnostic & Personalized Medicine
    • 13.6.3. Agricultural Biotechnology
    • 13.6.4. Animal Genetics
    • 13.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
  • 13.7. Market Attractiveness, by Application
  • 13.8. Market Value Forecast, by End-user, 2020-2034
    • 13.8.1. Pharmaceutical & Biopharmaceutical Companies
    • 13.8.2. Diagnostic & Research Laboratories
    • 13.8.3. Academic Institutes
    • 13.8.4. Others (Animal and Aquagenetics Companies, etc.)
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Product & Service
    • 13.11.2. By Technology
    • 13.11.3. By Application
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America Genotyping Assays Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product & Service, 2020-2034
    • 14.2.1. Reagents & Kits
    • 14.2.2. Genotyping Services
    • 14.2.3. Instruments
      • 14.2.3.1. Sequences & Amplifiers
      • 14.2.3.2. Analyzers
    • 14.2.4. Bioinformatics
      • 14.2.4.1. Software
      • 14.2.4.2. Services
  • 14.3. Market Attractiveness, by Product & Service
  • 14.4. Market Value Forecast, by Technology, 2020-2034
    • 14.4.1. PCR
      • 14.4.1.1. Real-time PCR
      • 14.4.1.2. Digital PCR
    • 14.4.2. Microarrays
    • 14.4.3. Sequencing
      • 14.4.3.1. NGS
      • 14.4.3.2. Pyrosequencing
      • 14.4.3.3. Sanger Sequencing
    • 14.4.4. Capillary Electrophoresis
      • 14.4.4.1. Amplified Fragment Length Polymorphism
      • 14.4.4.2. Restricted Fragment Length Polymorphism
      • 14.4.4.3. Single-Stranded Conformation Polymorphism
    • 14.4.5. MALDI-TOF
    • 14.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
  • 14.5. Market Attractiveness, by Technology
  • 14.6. Market Value Forecast, by Application, 2020-2034
    • 14.6.1. Pharmacogenomics
    • 14.6.2. Diagnostic & Personalized Medicine
    • 14.6.3. Agricultural Biotechnology
    • 14.6.4. Animal Genetics
    • 14.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
  • 14.7. Market Attractiveness, by Application
  • 14.8. Market Value Forecast, by End-user, 2020-2034
    • 14.8.1. Pharmaceutical & Biopharmaceutical Companies
    • 14.8.2. Diagnostic & Research Laboratories
    • 14.8.3. Academic Institutes
    • 14.8.4. Others (Animal and Aquagenetics Companies, etc.)
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Product & Service
    • 14.11.2. By Technology
    • 14.11.3. By Application
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa Genotyping Assays Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product & Service, 2020-2034
    • 15.2.1. Reagents & Kits
    • 15.2.2. Genotyping Services
    • 15.2.3. Instruments
      • 15.2.3.1. Sequences & Amplifiers
      • 15.2.3.2. Analyzers
    • 15.2.4. Bioinformatics
      • 15.2.4.1. Software
      • 15.2.4.2. Services
  • 15.3. Market Attractiveness, by Product & Service
  • 15.4. Market Value Forecast, by Technology, 2020-2034
    • 15.4.1. PCR
      • 15.4.1.1. Real-time PCR
      • 15.4.1.2. Digital PCR
    • 15.4.2. Microarrays
    • 15.4.3. Sequencing
      • 15.4.3.1. NGS
      • 15.4.3.2. Pyrosequencing
      • 15.4.3.3. Sanger Sequencing
    • 15.4.4. Capillary Electrophoresis
      • 15.4.4.1. Amplified Fragment Length Polymorphism
      • 15.4.4.2. Restricted Fragment Length Polymorphism
      • 15.4.4.3. Single-Stranded Conformation Polymorphism
    • 15.4.5. MALDI-TOF
    • 15.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
  • 15.5. Market Attractiveness, by Technology
  • 15.6. Market Value Forecast, by Application, 2020-2034
    • 15.6.1. Pharmacogenomics
    • 15.6.2. Diagnostic & Personalized Medicine
    • 15.6.3. Agricultural Biotechnology
    • 15.6.4. Animal Genetics
    • 15.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
  • 15.7. Market Attractiveness, by Application
  • 15.8. Market Value Forecast, by End-user, 2020-2034
    • 15.8.1. Pharmaceutical & Biopharmaceutical Companies
    • 15.8.2. Diagnostic & Research Laboratories
    • 15.8.3. Academic Institutes
    • 15.8.4. Others (Animal and Aquagenetics Companies, etc.)
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Product & Service
    • 15.11.2. By Technology
    • 15.11.3. By Application
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2023)
  • 16.3. Company Profiles
    • 16.3.1. Illumina, Inc.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Thermo Fisher Scientific
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. QIAGEN N.V.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Agilent
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Danaher Corporation
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Roche
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. GE HealthCare
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Standard BioTools Inc.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. PerkinElmer
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Eurofins Scientific SE
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Bio-Rad Laboratories
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview
    • 16.3.12. Pacific Biosciences of California, Inc.
      • 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.12.2. Product Portfolio
      • 16.3.12.3. Financial Overview
      • 16.3.12.4. SWOT Analysis
      • 16.3.12.5. Strategic Overview
    • 16.3.13. GENEWIZ, Inc.
      • 16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.13.2. Product Portfolio
      • 16.3.13.3. Financial Overview
      • 16.3.13.4. SWOT Analysis
      • 16.3.13.5. Strategic Overview
    • 16.3.14. Integrated DNA Technologies, Inc.
      • 16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.14.2. Product Portfolio
      • 16.3.14.3. Financial Overview
      • 16.3.14.4. SWOT Analysis
      • 16.3.14.5. Strategic Overview

List of Tables

  • Table 01: Global Genotyping Assays Market Size (US$ Bn) Forecast, by Product & Service, 2020-2034
  • Table 02: Global Genotyping Assays Market Size (US$ Bn) Forecast, by Technology, 2020-2034
  • Table 03: Global Genotyping Assays Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 04: Global Genotyping Assays Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 05: Global Genotyping Assays Market Size (US$ Bn) Forecast, by Region, 2020-2034
  • Table 06: North America Genotyping Assays Market Size (US$ Bn) Forecast, by Country, 2020-2034
  • Table 07: North America Genotyping Assays Market Size (US$ Bn) Forecast, by Product & Service, 2020-2034
  • Table 08: North America Genotyping Assays Market Size (US$ Bn) Forecast, by Technology, 2020-2034
  • Table 09: North America Genotyping Assays Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 10: North America Genotyping Assays Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 11: Europe Genotyping Assays Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Genotyping Assays Market Size (US$ Bn) Forecast, by Product & Service, 2020-2034
  • Table 13: Europe Genotyping Assays Market Size (US$ Bn) Forecast, by Technology, 2020-2034
  • Table 14: Europe Genotyping Assays Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 15: Europe Genotyping Assays Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 16: Asia Pacific Genotyping Assays Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Genotyping Assays Market Size (US$ Bn) Forecast, by Product & Service, 2020-2034
  • Table 18: Asia Pacific Genotyping Assays Market Size (US$ Bn) Forecast, by Technology, 2020-2034
  • Table 19: Asia Pacific Genotyping Assays Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 20: Asia Pacific Genotyping Assays Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 21: Latin America Genotyping Assays Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Genotyping Assays Market Size (US$ Bn) Forecast, by Product & Service, 2020-2034
  • Table 23: Latin America Genotyping Assays Market Size (US$ Bn) Forecast, by Technology, 2020-2034
  • Table 24: Latin America Genotyping Assays Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 25: Latin America Genotyping Assays Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 26: Middle East & Africa Genotyping Assays Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Genotyping Assays Market Size (US$ Bn) Forecast, by Product & Service, 2020-2034
  • Table 28: Middle East & Africa Genotyping Assays Market Size (US$ Bn) Forecast, by Technology, 2020-2034
  • Table 29: Middle East & Africa Genotyping Assays Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 30: Middle East & Africa Genotyping Assays Market Size (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Genotyping Assays Market Size (US$ Bn), by Region, 2023 and 2034
  • Figure 02: Global Genotyping Assays Market Revenue (US$ Bn), by Product & Service, 2023
  • Figure 03: Global Genotyping Assays Market Value Share, by Product & Service, 2023
  • Figure 04: Global Genotyping Assays Market Revenue (US$ Bn), by Technology, 2023
  • Figure 05: Global Genotyping Assays Market Value Share, by Technology, 2023
  • Figure 06: Global Genotyping Assays Market Revenue (US$ Bn), by Application, 2023
  • Figure 07: Global Genotyping Assays Market Value Share, by Application, 2023
  • Figure 08: Global Genotyping Assays Market Revenue (US$ Bn), by End-user, 2023
  • Figure 09: Global Genotyping Assays Market Value Share, by End-user, 2023
  • Figure 10: Global Genotyping Assays Market Value Share, by Region, 2023
  • Figure 11: Global Genotyping Assays Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 12: Global Genotyping Assays Market Value Share Analysis, by Product & Service, 2023 and 2034
  • Figure 13: Global Genotyping Assays Market Attractiveness Analysis, by Product & Service, 2024-2034
  • Figure 14: Global Genotyping Assays Market Value Share Analysis, by Technology, 2023 and 2034
  • Figure 15: Global Genotyping Assays Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 16: Global Genotyping Assays Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 17: Global Genotyping Assays Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 18: Global Genotyping Assays Market Revenue (US$ Bn), by End-user, 2023
  • Figure 19: Global Genotyping Assays Market Value Share, by End-user, 2023
  • Figure 20: Global Genotyping Assays Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 21: Global Genotyping Assays Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 22: North America Genotyping Assays Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 23: North America Genotyping Assays Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 24: North America Genotyping Assays Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 25: North America Genotyping Assays Market Value Share Analysis, by Product & Service, 2023 and 2034
  • Figure 26: North America Genotyping Assays Market Value Share Analysis, by Technology, 2023 and 2034
  • Figure 27: North America Genotyping Assays Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 28: North America Genotyping Assays Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 29: North America Genotyping Assays Market Attractiveness Analysis, by Product & Service, 2024-2034
  • Figure 30: North America Genotyping Assays Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 31: North America Genotyping Assays Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 32: North America Genotyping Assays Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 33: Europe Genotyping Assays Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 34: Europe Genotyping Assays Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 35: Europe Genotyping Assays Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 36: Europe Genotyping Assays Market Value Share Analysis, by Product & Service, 2023 and 2034
  • Figure 37: Europe Genotyping Assays Market Value Share Analysis, by Technology, 2023 and 2034
  • Figure 38: Europe Genotyping Assays Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 39: Europe Genotyping Assays Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 40: Europe Genotyping Assays Market Attractiveness Analysis, by Product & Service, 2024-2034
  • Figure 41: Europe Genotyping Assays Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 42: Europe Genotyping Assays Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 43: Europe Genotyping Assays Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 44: Asia Pacific Genotyping Assays Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 45: Asia Pacific Genotyping Assays Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 46: Asia Pacific Genotyping Assays Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 47: Asia Pacific Genotyping Assays Market Value Share Analysis, by Product & Service, 2023 and 2034
  • Figure 48: Asia Pacific Genotyping Assays Market Value Share Analysis, by Technology, 2023 and 2034
  • Figure 49: Asia Pacific Genotyping Assays Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 50: Asia Pacific Genotyping Assays Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 51: Asia Pacific Genotyping Assays Market Attractiveness Analysis, by Product & Service, 2024-2034
  • Figure 52: Asia Pacific Genotyping Assays Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 53: Asia Pacific Genotyping Assays Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 54: Asia Pacific Genotyping Assays Market Attractiveness Analysis, by End-user, 2023-2034
  • Figure 55: Latin America Genotyping Assays Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 56: Latin America Genotyping Assays Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 57: Latin America Genotyping Assays Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 58: Latin America Genotyping Assays Market Value Share Analysis, by Product & Service, 2023 and 2034
  • Figure 59: Latin America Genotyping Assays Market Value Share Analysis, by Technology, 2023 and 2034
  • Figure 60: Latin America Genotyping Assays Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 61: Latin America Genotyping Assays Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 62: Latin America Genotyping Assays Market Attractiveness Analysis, by Product & Service, 2024-2034
  • Figure 63: Latin America Genotyping Assays Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 64: Latin America Genotyping Assays Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 65: Latin America Genotyping Assays Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 66: Middle East & Africa Genotyping Assays Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 67: Middle East & Africa Genotyping Assays Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 68: Middle East & Africa Genotyping Assays Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 69: Middle East & Africa Genotyping Assays Market Value Share Analysis, by Product & Service, 2023 and 2034
  • Figure 70: Middle East & Africa Genotyping Assays Market Value Share Analysis, by Technology, 2023 and 2034
  • Figure 71: Middle East & Africa Genotyping Assays Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 72: Middle East & Africa Genotyping Assays Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 73: Middle East & Africa Genotyping Assays Market Attractiveness Analysis, by Product & Service, 2024-2034
  • Figure 74: Middle East & Africa Genotyping Assays Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 75: Middle East & Africa Genotyping Assays Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 76: Middle East & Africa Genotyping Assays Market Attractiveness Analysis, by End-user, 2024-2034